BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 20421449)

  • 1. Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling.
    Hartmann EM; Campo E; Wright G; Lenz G; Salaverria I; Jares P; Xiao W; Braziel RM; Rimsza LM; Chan WC; Weisenburger DD; Delabie J; Jaffe ES; Gascoyne RD; Dave SS; Mueller-Hermelink HK; Staudt LM; Ott G; Beà S; Rosenwald A
    Blood; 2010 Aug; 116(6):953-61. PubMed ID: 20421449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-resolution genomic screening in mantle cell lymphoma--specific changes correlate with genomic complexity, the proliferation signature and survival.
    Halldórsdóttir AM; Sander B; Göransson H; Isaksson A; Kimby E; Mansouri M; Rosenquist R; Ehrencrona H
    Genes Chromosomes Cancer; 2011 Feb; 50(2):113-21. PubMed ID: 21117067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uniparental disomies, homozygous deletions, amplifications, and target genes in mantle cell lymphoma revealed by integrative high-resolution whole-genome profiling.
    Beà S; Salaverria I; Armengol L; Pinyol M; Fernández V; Hartmann EM; Jares P; Amador V; Hernández L; Navarro A; Ott G; Rosenwald A; Estivill X; Campo E
    Blood; 2009 Mar; 113(13):3059-69. PubMed ID: 18984860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated genomic and expression profiling in mantle cell lymphoma: identification of gene-dosage regulated candidate genes.
    Schraders M; Jares P; Bea S; Schoenmakers EF; van Krieken JH; Campo E; Groenen PJ
    Br J Haematol; 2008 Oct; 143(2):210-21. PubMed ID: 18699851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma.
    Rosenwald A; Wright G; Wiestner A; Chan WC; Connors JM; Campo E; Gascoyne RD; Grogan TM; Muller-Hermelink HK; Smeland EB; Chiorazzi M; Giltnane JM; Hurt EM; Zhao H; Averett L; Henrickson S; Yang L; Powell J; Wilson WH; Jaffe ES; Simon R; Klausner RD; Montserrat E; Bosch F; Greiner TC; Weisenburger DD; Sanger WG; Dave BJ; Lynch JC; Vose J; Armitage JO; Fisher RI; Miller TP; LeBlanc M; Ott G; Kvaloy S; Holte H; Delabie J; Staudt LM
    Cancer Cell; 2003 Feb; 3(2):185-97. PubMed ID: 12620412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole genome copy number analysis in search of new prognostic biomarkers in first line treatment of mantle cell lymphoma. A study by the LYSA group.
    Le Bris Y; Magrangeas F; Moreau A; Chiron D; Guérin-Charbonnel C; Theisen O; Pichon O; Canioni D; Burroni B; Maisonneuve H; Thieblemont C; Oberic L; Gyan E; Pellat-Deceunynck C; Hermine O; Delfau-Larue MH; Tessoulin B; Béné MC; Minvielle S; Le Gouill S
    Hematol Oncol; 2020 Oct; 38(4):446-455. PubMed ID: 32472610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter methylation of PARG1, a novel candidate tumor suppressor gene in mantle-cell lymphomas.
    Ripperger T; von Neuhoff N; Kamphues K; Emura M; Lehmann U; Tauscher M; Schraders M; Groenen P; Skawran B; Rudolph C; Callet-Bauchu E; van Krieken JH; Schlegelberger B; Steinemann D
    Haematologica; 2007 Apr; 92(4):460-8. PubMed ID: 17488656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature.
    Salaverria I; Zettl A; Beà S; Moreno V; Valls J; Hartmann E; Ott G; Wright G; Lopez-Guillermo A; Chan WC; Weisenburger DD; Gascoyne RD; Grogan TM; Delabie J; Jaffe ES; Montserrat E; Muller-Hermelink HK; Staudt LM; Rosenwald A; Campo E
    J Clin Oncol; 2007 Apr; 25(10):1216-22. PubMed ID: 17296973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma.
    Greiner TC; Dasgupta C; Ho VV; Weisenburger DD; Smith LM; Lynch JC; Vose JM; Fu K; Armitage JO; Braziel RM; Campo E; Delabie J; Gascoyne RD; Jaffe ES; Muller-Hermelink HK; Ott G; Rosenwald A; Staudt LM; Im MY; Karaman MW; Pike BL; Chan WC; Hacia JG
    Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2352-7. PubMed ID: 16461462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mantle-cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome.
    Rubio-Moscardo F; Climent J; Siebert R; Piris MA; Martín-Subero JI; Nieländer I; Garcia-Conde J; Dyer MJ; Terol MJ; Pinkel D; Martinez-Climent JA
    Blood; 2005 Jun; 105(11):4445-54. PubMed ID: 15718413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mantle cell lymphoma: transcriptional regulation by microRNAs.
    Di Lisio L; Gómez-López G; Sánchez-Beato M; Gómez-Abad C; Rodríguez ME; Villuendas R; Ferreira BI; Carro A; Rico D; Mollejo M; Martínez MA; Menárguez J; Díaz-Alderete A; Gil J; Cigudosa JC; Pisano DG; Piris MA; Martínez N
    Leukemia; 2010 Jul; 24(7):1335-42. PubMed ID: 20485376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of gene copy number aberrations in mantle cell lymphoma by a single quantitative multiplex PCR assay: clinicopathological relevance and prognosis value.
    Jardin F; Picquenot JM; Parmentier F; Ruminy P; Cornic M; Penther D; Bertrand P; Lanic H; Cassuto O; Humbrecht C; Lemasle E; Wautier A; Bastard C; Tilly H
    Br J Haematol; 2009 Sep; 146(6):607-18. PubMed ID: 19594747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggressive morphologic variants of mantle cell lymphoma characterized with high genomic instability showing frequent chromothripsis, CDKN2A/B loss, and TP53 mutations: A multi-institutional study.
    Streich L; Sukhanova M; Lu X; Chen YH; Venkataraman G; Mathews S; Zhang S; Kelemen K; Segal J; Gao J; Gordon L; Chen Q; Behdad A
    Genes Chromosomes Cancer; 2020 Aug; 59(8):484-494. PubMed ID: 32277542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma.
    Chiarle R; Budel LM; Skolnik J; Frizzera G; Chilosi M; Corato A; Pizzolo G; Magidson J; Montagnoli A; Pagano M; Maes B; De Wolf-Peeters C; Inghirami G
    Blood; 2000 Jan; 95(2):619-26. PubMed ID: 10627471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis.
    Iqbal J; Shen Y; Liu Y; Fu K; Jaffe ES; Liu C; Liu Z; Lachel CM; Deffenbacher K; Greiner TC; Vose JM; Bhagavathi S; Staudt LM; Rimsza L; Rosenwald A; Ott G; Delabie J; Campo E; Braziel RM; Cook JR; Tubbs RR; Gascoyne RD; Armitage JO; Weisenburger DD; McKeithan TW; Chan WC
    Blood; 2012 May; 119(21):4939-48. PubMed ID: 22490335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of genetic changes in MCL by interphase FISH on tissue sections.
    Sander B; Wallblom A; Ekroth A; Porwit A; Kimby E
    Leuk Lymphoma; 2007 Jul; 48(7):1344-52. PubMed ID: 17613764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the Fondazione Italiana Linfomi MCL-0208 trial.
    Bomben R; Ferrero S; D'Agaro T; Dal Bo M; Re A; Evangelista A; Carella AM; Zamò A; Vitolo U; Omedè P; Rusconi C; Arcaini L; Rigacci L; Luminari S; Piccin A; Liu D; Wiestner A; Gaidano G; Cortelazzo S; Ladetto M; Gattei V
    Haematologica; 2018 May; 103(5):849-856. PubMed ID: 29472356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA expression profiles identify subtypes of mantle cell lymphoma with different clinicobiological characteristics.
    Navarro A; Clot G; Prieto M; Royo C; Vegliante MC; Amador V; Hartmann E; Salaverria I; Beà S; Martín-Subero JI; Rosenwald A; Ott G; Wiestner A; Wilson WH; Campo E; Hernández L
    Clin Cancer Res; 2013 Jun; 19(12):3121-9. PubMed ID: 23640973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of mantle-cell lymphoma: all oncogenic roads lead to dysregulation of cell cycle and DNA damage response pathways.
    Fernàndez V; Hartmann E; Ott G; Campo E; Rosenwald A
    J Clin Oncol; 2005 Sep; 23(26):6364-9. PubMed ID: 16155021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of genomic copy number alterations of malignant lymphomas and its application for diagnosis].
    Tagawa H
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):975-82. PubMed ID: 17637530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.